|Hepatitis C Infections in Hospitals Show Need for Tight Infection Control ...|
In one case, two New Jersey patients (one of them had hepatitis C) received an injection of the anesthetic propofol from the same medication cart. In the other instance, two Wisconsin patients (one of them had hepatitis C) received kidneys that had ...
WebMD - Fri, 27 Feb 2015 13:22
|New Call for Infection Control in Wake of HCV Transmissions|
Medscape - Fri, 27 Feb 2015 03:09
|Doctor Panel to Weigh Hepatitis C Drugs' Costs in Guidelines|
(Bloomberg) -- An influential advisory panel of doctors and health experts will for the first time address the cost-effectiveness of pricey hepatitis C drugs in updated guidelines that may change prescribing and coverage for the medicines. The 30 ...
Bloomberg - Fri, 27 Feb 2015 11:52
|Gilead Taking Giant Leap To Serve The Hepatitis C Market Of Developing ...|
GuruFocus.com (registration) - Thu, 26 Feb 2015 09:27
|Gilead dodges billions in taxes as money rolls in from hepatitis C drugs|
Santa Cruz Sentinel - Thu, 26 Feb 2015 11:52
|Gilead's Sovaldi wins NICE approval but faces access delay|
PMLiVE - Wed, 25 Feb 2015 16:23
|Tax break for Gilead as overseas profits jump 81%|
Irish Times - Thu, 26 Feb 2015 11:52
|India's Natco Pharma ties up with Gilead on hepatitis C drugs|
MUMBAI, March 2 (Reuters) - India's Natco Pharma Limited said on Monday it signed a licensing deal with Gilead Sciences Inc to make and sell generic versions of the U.S. drugmaker's chronic hepatitis C medicines. Drugs under the deal include sofosbuvir ...
Reuters - Sun, 01 Mar 2015 22:33
|Natco, Gilead sign non-exclusive deal for hepatitis C drugs|
Business Standard - Sun, 01 Mar 2015 23:07
|Deal with Gilead Sciences lifts Natco Pharma shares|
Hindu Business Line - Sun, 01 Mar 2015 22:56
|Natco, Gilead sign nonexclusive deal for hepatitis C|
Press Trust of India - Sun, 01 Mar 2015 23:07
|Natco Pharma inks nonexclusive licensing pact with Gilead Sciences|
Mint Market Info - Sun, 01 Mar 2015 22:45
|Combo Drug Shows High Hepatitis C Cure Rates in Patients Coinfected with HIV|
An interferon/ribavirin-free pill that combines two drugs to treat patients with certain genotypes of hepatitis C who are also infected with HIV was found to be highly effective in a 12-week trial, clearing the hepatitis C virus from almost all the ...
HCPLive - Sun, 01 Mar 2015 08:05
|Bristol hep C drug helps cure 97 pct of HIV coinfected patients-study|
Feb 26 (Reuters) - Ninety-seven percent of hepatitis C patients also infected with HIV were cured of the liver-destroying virus after 12 weeks of treatment with Bristol-Myers Squibb's daclatasvir and Gilead Sciences' Sovaldi, according to data from a ...
Reuters - Thu, 26 Feb 2015 12:15
|Sovaldi-Daklinza combo cures hep C in co-infected HIV patients|
PMLiVE - Fri, 27 Feb 2015 03:49
|Bristol-Myers: Drug combo cured hepatitis C in 97 percent of patients also ...|
Fox Business - Thu, 26 Feb 2015 15:48
|ALLY Trial Demonstrates 97% Hepatitis C Cure Rates Among Patients ...|
Business Wire (press release) - Thu, 26 Feb 2015 12:15
|ALLY-2 Results: Near Total Hepatitis C-HIV Cure Rate|
HCPLive - Thu, 26 Feb 2015 13:45
|NS5A/ NS3 Combo Hepatitis C Treatment Delivers Excellent Sustained Virologic ...|
A drug combination of daclatasvir and asunaprevir plus interferon/ribavirin had high success rates in a 24-week clinical trial for treatment of hepatitis C in patients who also have HIV, according to study results released at the annual Conference on ...
HCPLive - Sun, 01 Mar 2015 08:05
|Hepatitis C: Hunting the silent killer|
It is thought that in the west, hepatitis C is most common in those who have shared needles, or who received blood transfusions or tattoos before the virus was discovered. In low-income countries many transmissions result from unsterile invasive ...
The Guardian - Tue, 24 Feb 2015 22:00
|Mylan to Distribute Gilead's Hepatitis C Drugs in India|
Mylan Inc. 's Indian subsidiary will be the exclusive distributor of Gilead Sciences Inc. 's hepatitis C treatments in that country, in the latest move in the pharmaceutical wars over the market for the liver disease. Shares of both Gilead and Mylan ...
Wall Street Journal - Mon, 23 Feb 2015 05:30
|Mylan will distribute Gilead's hepatitis C medication in India|
National Monitor - Mon, 23 Feb 2015 07:45